Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a ... comparative studies have been performed with metoprolol, a β 1-selective "second-generation ...

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

Metoprolol is a beta-blocker approved by the Food and Drug Administration (FDA) to treat several cardiovascular conditions, including high blood pressure, heart failure, and angina (chest pain).

Specifically, COPERNICUS (led in the UK by Professor Coats at Imperial) showed general efficacy of beta-blockers in heart failure; COMET (designed and led by Professor Poole-Wilson at Imperial) showed ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.

They're prescribed to people with some irregular heart rhythms, heat attacks, heart failure ... the eight most common generic beta blocker drugs are metoprolol, carvedilol, atenolol, propranolol ...

Metoprolol is a beta-blocker used in the treatment of hypertension and angina and used to reduce mortality ... prevention of cardiac death and reinfarction after the acute phase of myocardial ...